<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tahara YK</submitter><funding>Alexander von Humboldt-Stiftung</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>2606-2615</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7061906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(12)</volume><pubmed_abstract>Oxidative damage in DNA is one of the primary sources of mutations in the cell. The activities of repair enzymes 8-oxoguanine DNA glycosylase (OGG1) and human MutT Homologue 1 (NUDT1 or MTH1), which work together to ameliorate this damage, are closely linked to mutagenesis, genotoxicity, cancer, and inflammation. Here we have undertaken the development of small-molecule dual inhibitors of the two enzymes as tools to test the relationships between these pathways and disease. The compounds preserve key structural elements of known inhibitors of the two enzymes, and they were synthesized and assayed with recently developed luminescence assays of the enzymes. Further structural refinement of initial lead molecules yielded compound &lt;b>5&lt;/b> (SU0383) with IC&lt;sub>50&lt;/sub>(NUDT1) = 0.034 μM and IC</pubmed_abstract><journal>ACS chemical biology</journal><pubmed_title>Dual Inhibitors of 8-Oxoguanine Surveillance by OGG1 and NUDT1.</pubmed_title><pmcid>PMC7061906</pmcid><funding_grant_id>R01 GM110050</funding_grant_id><funding_grant_id>R01 CA217809</funding_grant_id><funding_grant_id>P30 CA124435</funding_grant_id><funding_grant_id>CA217809</funding_grant_id><funding_grant_id>R01 GM067201</funding_grant_id><funding_grant_id>GM067201</funding_grant_id><funding_grant_id>GM110050</funding_grant_id><pubmed_authors>Hebenbrock M</pubmed_authors><pubmed_authors>Kool ET</pubmed_authors><pubmed_authors>Kietrys AM</pubmed_authors><pubmed_authors>Tahara YK</pubmed_authors><pubmed_authors>Wilson DL</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dual Inhibitors of 8-Oxoguanine Surveillance by OGG1 and NUDT1.</name><description>Oxidative damage in DNA is one of the primary sources of mutations in the cell. The activities of repair enzymes 8-oxoguanine DNA glycosylase (OGG1) and human MutT Homologue 1 (NUDT1 or MTH1), which work together to ameliorate this damage, are closely linked to mutagenesis, genotoxicity, cancer, and inflammation. Here we have undertaken the development of small-molecule dual inhibitors of the two enzymes as tools to test the relationships between these pathways and disease. The compounds preserve key structural elements of known inhibitors of the two enzymes, and they were synthesized and assayed with recently developed luminescence assays of the enzymes. Further structural refinement of initial lead molecules yielded compound &lt;b>5&lt;/b> (SU0383) with IC&lt;sub>50&lt;/sub>(NUDT1) = 0.034 μM and IC</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2026-04-16T21:09:07.203Z</modification><creation>2020-10-29T14:22:46Z</creation></dates><accession>S-EPMC7061906</accession><cross_references><pubmed>31622553</pubmed><doi>10.1021/acschembio.9b00490</doi></cross_references></HashMap>